Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDr. Martens Regulatory News (DOCS)

Share Price Information for Dr. Martens (DOCS)

Share Price is delayed by 15 minutes
Get Live Data
70.10    0.10 (0.14%)
Bid:
69.80
Ask:
70.30
Spread: 0.50 (0.716%)
Market Cap: £670.92m
DOCS Live PriceLast checked at - London Stock Exchange

Intraday Dr. Martens Share Chart

Directorate Change

24 Mar 2023 07:00

RNS Number : 0822U
Dr. Martens PLC
24 March 2023
 

Dr. Martens plc

APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

Dr. Martens plc ('the Company') today announces that, following a comprehensive search and selection process, Andrew Harrison will join the Board as an Independent Non-Executive Director with effect from 1 May 2023.

 

Andrew is a managing partner at consumer brand investment firm Freston Ventures and Senior Independent Director at Ocado Group plc, proprietor of the Ocado Smart Platform and joint owner of online grocer Ocado Retail Limited, where he is also chair of the Remuneration Committee and designated Non-Executive Director for engagement with the workforce. He built his executive career over more than two decades at Carphone Warehouse, where he served as Chief Executive and Chair. As a member of the early founding team, he drove the growth and international expansion of Carphone Warehouse from a small, privately owned retailer to established market leader and FTSE constituent, subsequently leading the merger of the business with Dixons in 2014, where he was Deputy Chief Executive.

 

Paul Mason, Chairman, said:

 

"I am delighted to welcome Andrew to the Dr. Martens Board. He brings a wealth of expertise of consumer facing and technology focused businesses and a highly entrepreneurial mindset. His significant prior experience as both a Chief Executive and Non-Executive Director of large, listed companies will bolster the Board and will be invaluable to the business as we embark on the next chapter of the Dr. Martens story."

 

On joining the Board, Andrew will also become a member of the Audit, Remuneration and Nomination Committees.

 

The Company confirms that there is no further information required to be disclosed pursuant to paragraph 9.6.13 of the UK Listing Rules.

 

 

Enquiries

 

Investors and analysts

Mark Blythman, Interim Director of Investor Relations +44 7570 871207

mark.blythman@drmartens.com

Media

Gill Hammond, Director of Communications +44 7384 214248

 

H/Advisors Maitland

Rhys Jones +44 7881 996460

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DMs" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. 

 

The Company listed successfully on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEAFUDEDSEED
Date   Source Headline
17th Nov 20236:21 pmRNSTransaction in Own Shares
16th Nov 20236:23 pmRNSTransaction in Own Shares
16th Nov 20237:00 amRNSChief Brand Officer Appointment
15th Nov 20236:13 pmRNSTransaction in Own Shares
14th Nov 20235:58 pmRNSTransaction in Own Shares
14th Nov 202312:41 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSCFO Appointment
13th Nov 20236:06 pmRNSTransaction in Own Shares
10th Nov 20236:24 pmRNSTransaction in Own Shares
9th Nov 20236:03 pmRNSTransaction in Own Shares
8th Nov 20235:56 pmRNSTransaction in Own Shares
7th Nov 20236:23 pmRNSTransaction in Own Shares
6th Nov 20236:23 pmRNSTransaction in Own Shares
3rd Nov 20236:03 pmRNSTransaction in Own Shares
2nd Nov 20236:15 pmRNSTransaction in Own Shares
2nd Nov 20237:00 amRNSBlock listing application
1st Nov 20236:02 pmRNSTransaction in Own Shares
1st Nov 20233:47 pmRNSTotal Voting Rights
24th Oct 20235:38 pmRNSTransaction in Own Shares
23rd Oct 20236:19 pmRNSTransaction in Own Shares
20th Oct 20235:49 pmRNSTransaction in Own Shares
19th Oct 20235:55 pmRNSTransaction in Own Shares
18th Oct 20235:40 pmRNSTransaction in Own Shares
17th Oct 20236:00 pmRNSTransaction in Own Shares
16th Oct 20236:19 pmRNSTransaction in Own Shares
13th Oct 20235:16 pmRNSTransaction in Own Shares
12th Oct 20236:27 pmRNSDirector/PDMR Shareholding
12th Oct 20236:07 pmRNSTransaction in Own Shares
11th Oct 20236:24 pmRNSTransaction in Own Shares
10th Oct 20236:24 pmRNSTransaction in Own Shares
9th Oct 20235:37 pmRNSTransaction in Own Shares
6th Oct 20236:23 pmRNSTransaction in Own Shares
5th Oct 20236:21 pmRNSTransaction in Own Shares
4th Oct 20236:12 pmRNSTransaction in Own Shares
3rd Oct 20235:48 pmRNSTransaction in Own Shares
2nd Oct 20236:20 pmRNSTransaction in Own Shares
28th Sep 20235:36 pmRNSTransaction in Own Shares
27th Sep 20236:21 pmRNSTransaction in Own Shares
26th Sep 20235:55 pmRNSTransaction in Own Shares
25th Sep 20235:50 pmRNSTransaction in Own Shares
22nd Sep 20236:13 pmRNSTransaction in Own Shares
21st Sep 20236:18 pmRNSTransaction in Own Shares
20th Sep 20236:14 pmRNSTransaction in Own Shares
19th Sep 20235:47 pmRNSTransaction in Own Shares
18th Sep 20236:23 pmRNSTransaction in Own Shares
15th Sep 20236:20 pmRNSTransaction in Own Shares
14th Sep 20236:21 pmRNSTransaction in Own Shares
14th Sep 20237:00 amRNSProduct and Brand teach-in event
13th Sep 20236:23 pmRNSTransaction in Own Shares
12th Sep 20236:14 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.